Literature DB >> 10627650

Cerebral toxoplasmosis - a late complication of allogeneic haematopoietic stem cell transplantation.

S Zver1, P Cernelc, U Mlakar, J Pretnar.   

Abstract

Toxoplasma gondii infection reactivation predominantly occurs among patients after allogeneic haematopoietic stem cell transplantation. Mostly, reactivation occurs during first 3 months after transplant, especially when risk factors are present. We report a case of late cerebral toxoplasmosis reactivation, which was probably triggered by a brief course of corticosteroids, administered for chronic graft-versus-host disease (cGVHD). In the presence of risk factors, such as cGVHD, prophylactic treatment for toxoplasmosis should be reinstituted; Trimethoprim-sulfamethoxasole most probably prevented earlier reactivation of toxoplasmosis in our patient.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10627650     DOI: 10.1038/sj.bmt.1702075

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  4 in total

1.  Cerebral toxoplasmosis after autologous peripheral blood stem cell transplantation.

Authors:  M López-Duarte; A Insunza; E Conde; A Iriondo; F Mazorra; A Zubizarreta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-08-27       Impact factor: 3.267

2.  Timely diagnosis of disseminated toxoplasmosis by sputum examination.

Authors:  Sophy Laibe; Stéphane Ranque; Catherine Curtillet; Françoise Faraut; Henri Dumon; Jacqueline Franck
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

3.  Late-Onset Cerebral Toxoplasmosis After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Ahmed M Khalaf; Mahmoud A Hashim; Mohammed Alsharabati; Kenneth Fallon; Joel K Cure; Peter Pappas; Shin Mineishi; Ayman Saad
Journal:  Am J Case Rep       Date:  2017-03-10

4.  Transmission of Toxoplasma gondii Infection Due to Bone Marrow Transplantation: Validation by an Experimental Model.

Authors:  Carolina Salomão Lopes; Tamires Lopes Silva; Julio Cesar Neves de Almeida; Lucas Vasconcelos Soares Costa; Tiago Wilson Patriarca Mineo; José Roberto Mineo
Journal:  Front Med (Lausanne)       Date:  2019-10-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.